Baidu
map

Nat Commun:肿瘤—睾丸基因表达模式有助于揭开肿瘤发生的秘密

2016-01-31 MedSci MedSci原创

<div class="p1Textcen font14" id="Zoom"><p>来自南京医科大学的研究人员报告称,他们在19种<span class="tip_s">癌症</span>类型中系统鉴别了呈肿瘤—睾丸(Cancer-testis,CT)基因表达模式的基因。他们的研究成果发布在1月27日的《自然通讯》(Nature Communications)杂志上。<span style="font-size: 9pt;">南京医科大学的</span>胡志斌(Zhibin Hu)教授、沙家豪(Jiahao Sha)教授和沈洪兵(Hongbing Shen)是这篇论文的共同通讯作者。</p><p>肿瘤—睾丸(Cancer-testis,CT)基因表达模式指提原本仅仅在睾丸系统(生殖系统)表达的特异性基因,在肿瘤细胞中同样也呈现表达,是近年来研究的关注热点之一。<span style="text-indent: 28px;">肿瘤-睾丸抗原(Cancer-testis antigen,CTA)是一类具有特异性表达模式的肿瘤相关抗原,具有加速肿瘤形成,抵抗肿瘤细胞凋亡。类似基因如</sp

来自南京医科大学的研究人员报告称,他们在19种癌症类型中系统鉴别了呈肿瘤—睾丸(Cancer-testis,CT)基因表达模式的基因。他们的研究成果发布在1月27日的《自然通讯》(Nature Communications)杂志上。南京医科大学的胡志斌(Zhibin Hu)教授、沙家豪(Jiahao Sha)教授和沈洪兵(Hongbing Shen)是这篇论文的共同通讯作者。

肿瘤—睾丸(Cancer-testis,CT)基因表达模式指提原本仅仅在睾丸系统(生殖系统)表达的特异性基因,在肿瘤细胞中同样也呈现表达,是近年来研究的关注热点之一。肿瘤-睾丸抗原(Cancer-testis antigen,CTA)是一类具有特异性表达模式的肿瘤相关抗原,具有加速肿瘤形成,抵抗肿瘤细胞凋亡。类似基因如TSP50,ssx1,NY-ESO-1,CT45-5,CAGE,MAGE等。

肿瘤—睾丸基因的存在反映了精子发生(spermatogenesis)与肿瘤发生(tumorigenesis)之间的相似性。有可能它们的选择性表达模式可以帮助鉴别出癌症中的一些驱动基因。

在这项新研究中,南京医科大学的研究人员整合了来自多个数据库的转录组数据,在19个癌症类型中系统鉴别出了876个新的CT基因。他们探讨了这些基因与睾丸特异性调控元件(TSREs)之间的关系。提出了极端高水平表达的CT基因(EECTGs)是可以通过一些表观遗传机制激活的潜在驱动子。

研究人员发现了EECTGs与一些突变基因,如乳腺癌中PIK3CA基因的体细胞突变之间呈相互排斥关系。他们还提供了证据表明,启动子去甲基化和附近的非编码RNAs(CT-ncRNAs)可能是重新激活EECTG基因表达的两种机制。并证实了减数分裂相关EECTG (MEIOB)和邻近的CT-ncRNA在肺腺癌肿瘤发生中发挥作用。

新研究扩展了我们对于CT基因的认识,并为我们鉴别癌症中的表观遗传驱动基因提供了新思路,在未来这些表观遗传基因有可能成为癌症治疗的靶点。

胡志斌、沙家豪和沈洪兵三位教授近年来在各自的研究领域取得了不少骄人的研究成果。

原始出处:

Wang C, Gu Y, Zhang K, Xie K, Zhu M, Dai N, Jiang Y, Guo X, Liu M, Dai J, Wu L, Jin G, Ma H, Jiang T, Yin R, Xia Y, Liu L, Wang S, Shen B, Huo R, Wang Q, Xu L, Yang L, Huang X, Shen H, Sha J, Hu Z.Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types. Nat Commun. 2016 Jan 27;7:10499. doi: 10.1038/ncomms10499.

相关文献:

Zhong J, Chen Y, Liao X, Li J, Wang H, Wu C, Zou X, Yang G, Shi J, Luo L, Liu L, Deng J, Tang A.Testis expressed 19 is a novel cancer-testis antigen expressed in bladder cancer. Tumour Biol. 2015 Dec 22


Ghafouri-Fard S.Expression of cancer-testis antigens in stem cells: is it a potential drawback or an advantage incancer immunotherapy. Asian Pac J Cancer Prev. 2015;16(7):3079-81.


Ghafouri-Fard S.Expression of Cancer-Testis Antigens in Pediatric Cancers. Asian Pac J Cancer Prev. 2015;16(13):5149-52.

作者简介:

胡志斌教授:教育部***特聘教授和国家基金委杰出青年基金获得者,现任生殖医学国家重点实验室副主任,南京医科大学公共卫生学院副院长。主持科技部青年“973”项目、自然科学基金重大项目课题等多项。在Nature Genetics,J Clin Invest,J Clin Oncol等专业杂志上发表论文200多篇,SCI他引超过5000次。

沙家豪博士,男,1959年5月出生,南京医科大学特聘教授,博士生导师,生殖医学国家重点实验室主任和“配子发生的分子机制”学术带头人,科技部 “生殖与发育重大科学计划”专家组成员、“生殖健康的基础和临床研究”教育部创新团队带头人、国家杰出青年科学基金获得者、中国动物学会生殖生物学分会副理事长、江苏省解剖学会理事长、江苏省细胞遗传学会副理事长、《Asian J Androl》编委、《Chinese Science Bulletin》编委、《生殖医学杂志》常务编委、《中国男科杂志》编委、《男科学报》编委、《中国计划生育学杂志》编委和《国外医学》计划生育分册常务编委;在国内外SCI收录杂志发表论文70篇。

沈洪兵博士, 男,1964年5月出生,南京医科大学特聘教授,博士生导师。生殖医学国家重点实验室副主任,教育部“***”特聘教授,国家杰出青年科学基金获得者,新世纪百千万人才工程国家级人选,全国百篇优秀博士论文指导教师。现任国际肿瘤和分子流行病学专业期刊《Lung Cancer》、《Oncology Reports》、《International Journal of Molecular Epidemiology and Genetics》等杂志编委,并为《J Clin Oncol》、《Gut》、《Cancer Res》等10多个国际杂志审稿人。主要致力于环境与肿瘤的分子流行病学研究,作为通讯/第一作者发表SCI论文100余篇。作为第一完成人先后获教育部高校自然科学奖一等奖,江苏省科技进步二等奖及中华医学科技进步二等奖等。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2086846, encodeId=8a632086846be, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Sep 29 18:15:00 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880928, encodeId=ccf1188092837, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Dec 31 05:15:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63117, encodeId=dca76311e2e, content=那女生岂不是很尴尬。, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Wed Feb 03 20:16:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348012, encodeId=b52313480129b, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Tue Feb 02 08:15:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368311, encodeId=9fcf136831181, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Tue Feb 02 08:15:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62377, encodeId=df37623e77d, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sun Jan 31 18:52:00 CST 2016, time=2016-01-31, status=1, ipAttribution=)]
    2016-09-29 liuli5079
  2. [GetPortalCommentsPageByObjectIdResponse(id=2086846, encodeId=8a632086846be, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Sep 29 18:15:00 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880928, encodeId=ccf1188092837, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Dec 31 05:15:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63117, encodeId=dca76311e2e, content=那女生岂不是很尴尬。, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Wed Feb 03 20:16:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348012, encodeId=b52313480129b, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Tue Feb 02 08:15:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368311, encodeId=9fcf136831181, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Tue Feb 02 08:15:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62377, encodeId=df37623e77d, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sun Jan 31 18:52:00 CST 2016, time=2016-01-31, status=1, ipAttribution=)]
    2016-12-31 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=2086846, encodeId=8a632086846be, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Sep 29 18:15:00 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880928, encodeId=ccf1188092837, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Dec 31 05:15:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63117, encodeId=dca76311e2e, content=那女生岂不是很尴尬。, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Wed Feb 03 20:16:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348012, encodeId=b52313480129b, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Tue Feb 02 08:15:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368311, encodeId=9fcf136831181, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Tue Feb 02 08:15:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62377, encodeId=df37623e77d, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sun Jan 31 18:52:00 CST 2016, time=2016-01-31, status=1, ipAttribution=)]
    2016-02-03 pangshiwei

    那女生岂不是很尴尬。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2086846, encodeId=8a632086846be, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Sep 29 18:15:00 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880928, encodeId=ccf1188092837, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Dec 31 05:15:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63117, encodeId=dca76311e2e, content=那女生岂不是很尴尬。, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Wed Feb 03 20:16:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348012, encodeId=b52313480129b, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Tue Feb 02 08:15:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368311, encodeId=9fcf136831181, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Tue Feb 02 08:15:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62377, encodeId=df37623e77d, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sun Jan 31 18:52:00 CST 2016, time=2016-01-31, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2086846, encodeId=8a632086846be, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Sep 29 18:15:00 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880928, encodeId=ccf1188092837, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Dec 31 05:15:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63117, encodeId=dca76311e2e, content=那女生岂不是很尴尬。, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Wed Feb 03 20:16:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348012, encodeId=b52313480129b, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Tue Feb 02 08:15:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368311, encodeId=9fcf136831181, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Tue Feb 02 08:15:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62377, encodeId=df37623e77d, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sun Jan 31 18:52:00 CST 2016, time=2016-01-31, status=1, ipAttribution=)]
    2016-02-02 zhangph
  6. [GetPortalCommentsPageByObjectIdResponse(id=2086846, encodeId=8a632086846be, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Sep 29 18:15:00 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880928, encodeId=ccf1188092837, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Dec 31 05:15:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63117, encodeId=dca76311e2e, content=那女生岂不是很尴尬。, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Wed Feb 03 20:16:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348012, encodeId=b52313480129b, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Tue Feb 02 08:15:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368311, encodeId=9fcf136831181, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Tue Feb 02 08:15:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62377, encodeId=df37623e77d, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sun Jan 31 18:52:00 CST 2016, time=2016-01-31, status=1, ipAttribution=)]
    2016-01-31 李继凯

    收藏

    0

相关资讯

ASCO-GU 2016:复旦肿瘤基因预测模型助力肾癌精准医疗

在本次ASCO-GU会议上,由复旦大学附属肿瘤医院叶定伟教授牵头开展,万方宁、朱耀、韩成涛医师作为共同第一作者的一项研究入选POSTER。应本报邀请,他们发来了该研究的背景、结果、意义以及创新性等方面的介绍以飨读者。 摘要号526:预测高级别肾透明细胞癌分子模型的建立和验证 肾癌是常见的泌尿系统恶性肿瘤,随着体检的普及发病率显著升高。肾癌的治疗手段多样,包括保留肾单位手术、肾脏全切、冷冻消

Nature:肿瘤复发是死灰复燃,还是老根新芽?

来自美国,加拿大等数十个研究机构组成的一个国际研究小组发现的证据表明,在髓母细胞瘤(medulloblastoma)患者体内复发的癌症与原发肿瘤并不一定是同一来源。这项研究结果发表在近日的《自然》(Nature)杂志上,该研究描述了他们利用小鼠模型开展的遗传工作,对人类肿瘤进行的全基因组测序,他们的研究发现以及研究人员认为要更好地治疗患者需要去做的事情。 研究人员了解在手术切除首次发病的肿瘤后,

研究发现肿瘤微环境导致获得性耐药新机制

中科院上海健康所 研究发现肿瘤微环境导致获得性耐药新机制 中科院上海生科院上海交大医学院健康科学研究所孙宇研究组揭示了Wnt信号通路在肿瘤耐药性形成过程中的核心地位和分子机制,颠覆了人们对于SFRP2分子在很多癌型中对于Wnt通路拮抗作用的传统认识。相关成果近日在线发表于《癌基因》 。 研究人员以全基因组表达谱分析发现,一种与Wnt信号通路调控有关的可溶因子SFRP2在经过基因毒试剂处理

国内肿瘤领域液体活检公司汇总

肿瘤检测领域一个新的应用场景-液体活检正在朝我们扑过来,液体活检技术风起云涌! 液体活检对于我们来说其实并不陌生,例如目前已经较为成熟的NIPT就是液体活检技术,以前要对胎儿进行检测要进行“羊水穿刺”,这会造成一定的流产风险,而NIPT就是对母体外周血中游离的胎儿DNA进行检测,从而实现了无创检测。液态活检的另外一大应用是癌症领域,常规组织活检在癌症诊治中有一定的局限性: 第一,癌症有

Am J Med:恶性肿瘤患者能都使用利伐沙班治疗?

目前Xa因子直接抑制剂利伐沙班在高危人群中如静脉血栓栓塞伴活跃的恶性肿瘤患者中使用的临床数据仍缺乏。研究者对2013-3-1到2015-4-30在梅奥诊所接受口服抗凝剂利伐沙班治疗的深静脉血栓形成或肺栓塞患者进行了前瞻性研究,评估该疗法的安全性和有效性。该研究纳入了404名静脉血栓栓塞患者,其中296名使用利伐沙班治疗,对其随访3个月以上。纳入的研究者中有118(40%)名恶性肿瘤活跃的患者(51

Am J Gastroenterol:内镜下切除术治疗SETs的安全性研究

对于起源于固有肌层 (MP) 的上消化道上皮下肿瘤(SETs),选择内镜下切除目前是一个公认的技术,不过关于该疗法的并发症高度可变,且相关数据较少,因此研究者进行了一项研究,对一个大型病例系统探究内镜下切除术的安全性。该研究共纳入了2005-6到2014-12月的726名患者,涉及733例起源于MP的上消化道SETs,均在内镜下切除。主要结局指标为:完全切除率、围手术期穿孔率、围手术期出血量。研究

Baidu
map
Baidu
map
Baidu
map